Search the MBS

Both:

(a) percutaneous repositioning of sacral nerve lead or leads using fluoroscopic guidance, or open repositioning of sacral nerve lead or leads; and

(b) intra‑operative test stimulation, to correct displacement or unsatisfactory positioning, if inserted for the management of:

(i) detrusor over‑activity that has been refractory to at least 12 months conservative non‑surgical treatment; or

(ii) non‑obstructive urinary retention that has been refractory to at least 12 months conservative non‑surgical treatment;

other than a service to which item 36663 applies (H)

Multiple Operation Rule

Fee: $676.20 Benefit: 75% = $507.15

• Previous - Item 36663
• Next - Item 36665